Objective: The purpose of this research was to look at the relationship between insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) levels and the risk for breast cancer (BC) among women in the Gaza Strip.

Methods: This case-control study, which included 334 participants (112 women with BC as cases, and 222 women without BC as control), was conducted between January 2021 and August 2022. Research data for the cases were gathered at the Oncology Departments of the Gaza Strip's two hospitals, "Al- Shifa Hospital and Turkish Palestinian Friendship Hospital," as well as from the electronic records of the Screening Mammogram Unit at Al- Remal Clinic for controls. The information about the participants was gathered using a standardized questionnaire. The key variables related to BC were identified using multivariate logistic regression.

Results: According to multivariate logistic regression, participants' age was associated with an increase in the risk of BC (OR= 1.03; 95%CI, 1.007-1.060). There was an association between serum concentrations of fasting blood glucose (FBG) (OR= 1.027; 95% CI, 1.013-1.042), IGF-1 (OR= 1.010; 95% CI, 1.006-1.015), and the risk of BC, while there was no link between IGFBP-3 and the risk of BC. In an analysis of the risk according to menopausal status, premenopausal women were associated with an approximate 0.5 time decrease in risk of BC compared to women in post-menopause (OR= 0.428, 95% CI, 0.258, 0.710). Dairy product was also related to a decreased risk of BC.

Conclusion: The results suggest that age, lower physical activity, increased levels of FBG, and IGF- 1 increase the BC risk among females in the Gaza Strip. Meanwhile, premenopausal women and dairy products are linked to a reduction in the risk of BC. Furthermore, no link was found between IGFBP-3 and BC risk. Improving early BC detection rates in the Gaza Strip necessitates preventative interventions and screening for BC in the public and healthcare sectors.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162616PMC
http://dx.doi.org/10.31557/APJCP.2023.24.2.717DOI Listing

Publication Analysis

Top Keywords

igfbp-3 risk
12
gaza strip
12
risk
11
association serum
8
risk breast
8
breast cancer
8
cancer women
8
women gaza
8
insulin-like growth
8
multivariate logistic
8

Similar Publications

Purpose: There is controversy as to whether brain magnetic resonance imaging (MRI) should be performed on all children with growth hormone deficiency (GHD) including those judged to have mild GHD. This study was aimed to determine the frequency of pituitary or intracranial abnormalities in pediatric GHD and to identify risk factors that may predict pituitary or intracranial abnormalities.

Methods: A total of 95 pediatric GHD patients were included.

View Article and Find Full Text PDF

Recurrence of hepatocellular carcinoma (HCC) after ultrasound-guided microwave ablation (UGMWA) was a critical issue. Therefore, it is significant to identify the role of hypoxia-inducible factor 1 α (HIF-1α), insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3) in recurrence. HCC patients receiving UGMWA were divided into recurrence and no-recurrence groups.

View Article and Find Full Text PDF

m6A-related genes and their role in Parkinson's disease: Insights from machine learning and consensus clustering.

Medicine (Baltimore)

November 2024

Jilin Provincial Academy of Chinese Medicine Sciences, Changchun, Jilin Province, China.

Article Synopsis
  • Parkinson's disease (PD) is linked to low dopamine levels in the brain, and recent research suggests that RNA N6-methyladenosine (m6A) regulators may impact its progression, though their exact role remains unclear.
  • Using the GSE8397 dataset, the study identified 11 key m6A-related genes and applied a random forest model to select four candidate genes that could help predict PD risk, leading to the creation of a useful nomogram model.
  • The study further categorized PD into two distinct m6A clusters, revealing different immune cell infiltrations in each cluster, which suggests that understanding these m6A-related genes could improve personalized treatment strategies for PD.
View Article and Find Full Text PDF

Background: Medulloblastoma (MB) is a malignant pediatric central nervous system tumor that is prone to leptomeningeal metastasis. Currently, apart from magnetic resonance imaging and cerebrospinal fluid (CSF) cytology, there are no reliable biomarkers for MB progression. Cytokines are key proteins in signaling pathways in the tumor microenvironment and are closely related to tumor recurrence and progression.

View Article and Find Full Text PDF
Article Synopsis
  • The study assessed the effectiveness and safety of PEGylated-recombinant human growth hormone (PEG-rhGH) in children born small for gestational age (SGA).
  • Conducted in China, 96 SGA children were randomized to receive either a low dose (0.1 mg/kg/week) or high dose (0.2 mg/kg/week) of PEG-rhGH over 52 weeks.
  • Results showed significant improvements in height and growth velocity for those on the high dose compared to the low dose, with both treatments being well tolerated.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!